Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-071710
Filing Date
2014-12-01
Accepted
2014-12-01 06:13:36
Documents
1
Period of Report
2014-11-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3185
  Complete submission text file 0001209191-14-071710.txt   4529
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 01824
Business Address
Amello Jason (Reporting) CIK: 0001451805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 141256333

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations